Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

for
Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma
Location: Webster TX, Aventura FL
Sponsor: MediWound Ltd

Sex: All

Age: 18+

Code: NCT05157763

Phase1, Phase2, Recruiting

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

for
Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer,
Location: Houston TX
Sponsor: Critical Outcome Technologies Inc.

Sex: All

Age: 18+

Code: NCT02433626

Phase1, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Webster TX, Austin TX, San Antonio TX, Fort Worth TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase3, Recruiting

Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

for
Mental Health Wellness 1, Preterm Birth
Location: Webster TX
Sponsor: Microgen LLC

Sex: Female

Age: 18 - 45

Code: NCT05012072

Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Webster TX, Dallas TX, St Louis MO, Marietta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

for
Obesity
Location: Webster TX, Dilworth MN, Lake Forest CA
Sponsor: Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics

Sex: All

Age: 25 - 70+

Code: NCT07815678

Phase1, Phase2, Recruiting

A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

for
Cachexia
Location: Kingwood TX, Nashville TN, Omaha NE, Orlando FL,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05865535

Phase1, Recruiting

Tissue Repair Gel in Venous Leg Ulcers (US)

for
Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer,
Location: Houston TX, Lafayette LA, Bossier City LA,
Sponsor: TR Therapeutics

Sex: All

Age: 18+

Code: NCT06707090

Phase3, Recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

for
Endometrial Cancer, Endometrioid Adenocarcinoma,
Location: Houston TX, Orlando FL, Miami FL, Allentown PA,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT04291612

Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

for
Non-cystic Fibrosis Bronchiectasis
Location: Houston TX, Tyler TX, Birmingham AL, Kansas City KS,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Sex: All

Age: 18 - 70+

Code: NCT06559150

Phase2, Recruiting

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

for
Excessive Sleepiness, Shift-work Disorder
Location: Sugar Land TX, Houston TX, San Antonio TX, Kenner LA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06568367

Phase3, Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

for
Cataract, Presbyopia, Posterior Capsule Opacification
Location: Sugar Land TX, Wichita KS, Dothan AL, Omaha NE,
Sponsor: Bausch & Lomb Incorporated

Sex: All

Age: 22+

Code: NCT06060041

Recruiting

A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population

for
Breast Cancer
Location: Houston TX
Sponsor: Rose Imaging Specialists, P.A.

Sex: Female

Age: 30+

Code: NCT01569802

Recruiting

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

for
Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus, Wound
Location: Houston TX, Jackson TN, Columbus GA, Palmetto Bay FL,
Sponsor: Energenesis Biomedical Co., Ltd.

Sex: All

Age: 18+

Code: NCT05930210

Phase3, Recruiting

A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age

for
Chickenpox
Location: Houston TX, Richmond TX, Lafayette LA, Dallas TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1

Code: NCT06693895

Phase3, Recruiting

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

for
Idiopathic Hypersomnia
Location: Sugar Land TX, Sugarland TX, Austin TX, San Antonio TX,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06843590

Phase2, Recruiting

Feasibility of a Novel Technique for Pilonidal Wound Healing

for
Pilonidal Disease, Pilonidal Cyst, Pilonidal Sinus
Location: Houston TX
Sponsor: Southeast Clinical Research Associates, Houston, Texas

Sex: All

Age: 18+

Code: NCT02330159

Recruiting

Longitudinal Study of the Porphyrias

for
Acute Porphyrias, Cutaneous Porphyrias
Location: Galveston TX, Birmingham AL, Miami FL, Winston-Salem NC,
Sponsor: The American Porphyrias Expert Collaborative

Sex: All

Age: 0+

Code: NCT01561157

Recruiting
New

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

for
Diabetes Mellitus, Type 2
Location: Houston TX, Shavano Park TX, Memphis TN, Columbus GA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 10 - 18

Code: NCT07282613

Phase3, Recruiting

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

for
Systemic Lupus Erythematosus
Location: League City TX, Lake Charles LA, Red Oak TX, Memphis TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06133972

Phase3, Recruiting